Centers for Medicare & Medicaid Services Issues Prospective Payment Rates Updates for Inpatient Rehabilitation Facilities
Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2016
A Proposed Rule by the
Publication Date:
Agencies:
Dates: To be assured consideration, comments must be received at one of
Entry Type: Proposed Rule
Action: Proposed rule.
Document Citation: 80 FR 23331
Page: 23331 -23399 (69 pages)
CFR: 42 CFR 412
Agency/Docket Number: CMS-1624-P
RIN: 0938-AS45
Document Number: 2015-09617
Shorter URL: https://federalregister.gov/a/2015-09617
Action
Proposed Rule.
Summary
This proposed rule would update the prospective payment rates for inpatient rehabilitation facilities (IRFs) for federal fiscal year (FY) 2016 as required by the statute. We are also proposing to adopt an IRF-specific market basket that reflects the cost structures of only IRF providers, phase in the revised wage index changes, and revise and update quality measures and reporting requirements under the IRF quality reporting program (QRP).
DATES:
To be assured consideration, comments must be received at one of the addresses provided below, no later than
ADDRESSES:
In commenting, please refer to file code CMS-1624-P. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission.
You may submit comments in one of four ways (please choose only one of the ways listed):
1. Electronically. You may submit electronic comments on this regulation to http://www.regulations.gov. Follow the "Submit a comment" instructions.
2. By regular mail. You may mail written comments to the following address ONLY:
Please allow sufficient time for mailed comments to be received before the close of the comment period.
3. By express or overnight mail. You may send written comments to the following address ONLY:
4. By hand or courier. Alternatively, you may deliver (by hand or courier) your written comments ONLY to the following addresses prior to the close of the comment period:
a. For delivery in
(Because access to the interior of the
b. For delivery in
If you intend to deliver your comments to the
Comments erroneously mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed and received after the comment period.
For information on viewing public comments, see the beginning of the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
The IRF PPS Addenda along with other supporting documents and tables referenced in this proposed rule are available through the Internet on the CMS Web site at http://www.cms.hhs.gov/Medicare/Medicare-Fee-for-Service-Payment/InpatientRehabFacPPS/.
Inspection of Public Comments: All comments received before the close of the comment period are available for viewing by the public, including any personally identifiable or confidential business information that is included in a comment. We post all comments received before the close of the comment period on the following Web site as soon as possible after they have been received: http://www.regulations.gov. Follow the search instructions on that Web site to view public comments.
Comments received timely will also be available for public inspection as they are received, generally beginning approximately 3 weeks after publication of a document, at the headquarters of the
Executive Summary
A. Purpose
This proposed rule would update the payment rates for IRFs for FY 2016 (that is, for discharges occurring on or after
B. Summary of Major Provisions
In this proposed rule, we use the methods described in the FY 2015 IRF PPS final rule (79 FR 45872) to propose updates to the federal prospective payment rates for FY 2016 using updated FY 2014 IRF claims and the most recent available IRF cost report data. We are also proposing to adopt an IRF-specific market basket that reflects the cost structures of only IRF providers. We are proposing that the IRF-specific market basket will be used to update the IRF PPS base payment rate and to determine the FY 2016 labor-related share. We are also proposing to phase in the revised wage index changes, and revise and update quality measures and reporting requirements under the IRF QRP.
C. Summary of Impacts
<p>Provision Description ..... Transfers
FY 2016 IRF PPS payment rate update ..... The overall economic impact of this proposed rule is an estimated
Provision Description ..... Costs
New quality reporting program requirements ..... The total costs in FY 2016 for IRFs as a result of the proposed new quality reporting requirements are estimated to be
I. Background
A. Historical Overview of the IRF PPS
Section 1886(j) of the Act provides for the implementation of a per-discharge PPS for inpatient rehabilitation hospitals and inpatient rehabilitation units of a hospital (collectively, hereinafter referred to as IRFs). Payments under the IRF PPS encompass inpatient operating and capital costs of furnishing covered rehabilitation services (that is, routine, ancillary, and capital costs), but not direct graduate medical education costs, costs of approved nursing and allied health education activities, bad debts, and other services or items outside the scope of the IRF PPS. Although a complete discussion of the IRF PPS provisions appears in the original FY 2002 IRF PPS final rule (66 FR 41316) and the FY 2006 IRF PPS final rule (70 FR 47880), we are providing below a general description of the IRF PPS for fiscal years (FYs) 2002 through 2015.
Under the IRF PPS from FY 2002 through FY 2005, as described in the FY 2002 IRF PPS final rule (66 FR 41316), the federal prospective payment rates were computed across 100 distinct case-mix groups (CMGs). We constructed 95 CMGs using rehabilitation impairment categories (RICs), functional status (both motor and cognitive), and age (in some cases, cognitive status and age may not be a factor in defining a CMG). In addition, we constructed five special CMGs to account for very short stays and for patients who expire in the IRF.
For each of the CMGs, we developed relative weighting factors to account for a patient's clinical characteristics and expected resource needs. Thus, the weighting factors accounted for the relative difference in resource use across all CMGs. Within each CMG, we created tiers based on the estimated effects that certain comorbidities would have on resource use.
We established the federal PPS rates using a standardized payment conversion factor (formerly referred to as the budget-neutral conversion factor). For a detailed discussion of the budget-neutral conversion factor, please refer to our FY 2004 IRF PPS final rule (68 FR 45684 through 45685). In the FY 2006 IRF PPS final rule (70 FR 47880), we discussed in detail the methodology for determining the standard payment conversion factor.
We applied the relative weighting factors to the standard payment conversion factor to compute the unadjusted federal prospective payment rates under the IRF PPS from FYs 2002 through 2005. Within the structure of the payment system, we then made adjustments to account for interrupted stays, transfers, short stays, and deaths. Finally, we applied the applicable adjustments to account for geographic variations in wages (wage index), the percentage of low-income patients, location in a rural area (if applicable), and outlier payments (if applicable) to the IRFs' unadjusted federal prospective payment rates.
For cost reporting periods that began on or after
We established a CMS Web site as a primary information resource for the IRF PPS which is available at http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/InpatientRehabFacPPS/index.html. The Web site may be accessed to download or view publications, software, data specifications, educational materials, and other information pertinent to the IRF PPS.
Section 1886(j) of the Act confers broad statutory authority upon the Secretary to propose refinements to the IRF PPS. In the FY 2006 IRF PPS final rule (70 FR 47880) and in correcting amendments to the FY 2006 IRF PPS final rule (70 FR 57166) that we published on
In the FY 2007 IRF PPS final rule (71 FR 48354), we further refined the IRF PPS case-mix classification system (the CMG relative weights) and the case-level adjustments, to ensure that IRF PPS payments would continue to reflect as accurately as possible the costs of care. For a detailed discussion of the FY 2007 policy revisions, please refer to the FY 2007 IRF PPS final rule (71 FR 48354).
In the FY 2008 IRF PPS final rule (72 FR 44284), we updated the federal prospective payment rates and the outlier threshold, revised the IRF wage index policy, and clarified how we determine high-cost outlier payments for transfer cases. For more information on the policy changes implemented for FY 2008, please refer to the FY 2008 IRF PPS final rule (72 FR 44284), in which we published the final FY 2008 IRF federal prospective payment rates.
After publication of the FY 2008 IRF PPS final rule (72 FR 44284), section 115 of the
In the FY 2009 IRF PPS final rule (73 FR 46370), we updated the CMG relative weights, the average length of stay values, and the outlier threshold; clarified IRF wage index policies regarding the treatment of "
In the FY 2010 IRF PPS final rule (74 FR 39762) and in correcting amendments to the FY 2010 IRF PPS final rule (74 FR 50712) that we published on
After publication of the FY 2010 IRF PPS final rule (74 FR 39762), section 3401(d) of the Patient Protection and Affordable Care Act (Pub. L. 111-148, enacted on
Sections 1886(j)(3)(C)(ii)(II) and 1886(j)(3)(D)(i) of the Act defined the adjustments that were to be applied to the market basket increase factors in FYs 2010 and 2011. Under these provisions, the Secretary was required to reduce the market basket increase factor in FY 2010 by a 0.25 percentage point adjustment. Notwithstanding this provision, in accordance with section 3401(p) of the Affordable Care Act, the adjusted FY 2010 rate was only to be applied to discharges occurring on or after
In addition, sections 1886(j)(3)(C) and (D) of the Act also affected the FY 2010 IRF outlier threshold amount because they required an adjustment to the FY 2010 RPL market basket increase factor, which changed the standard payment conversion factor for FY 2010. Specifically, the original FY 2010 IRF outlier threshold amount was determined based on the original estimated FY 2010 RPL market basket increase factor of 2.5 percent and the standard payment conversion factor of
Sections 1886(j)(3)(c)(ii)(II) and 1886(j)(3)(D)(i) of the Act also required the Secretary to reduce the market basket increase factor in FY 2011 by a 0.25 percentage point adjustment. The FY 2011 IRF PPS notice (75 FR 42836) and the correcting amendments to the FY 2011 IRF PPS notice (75 FR 70013) described the required adjustments to the FY 2011 and FY 2010 IRF PPS federal prospective payment rates and outlier threshold amount for IRF discharges occurring on or after
In the FY 2012 IRF PPS final rule (76 FR 47836), we updated the IRF federal prospective payment rates, rebased and revised the RPL market basket, and established a new quality reporting program for IRFs in accordance with section 1886(j)(7) of the Act. We also revised regulation text for the purpose of updating and providing greater clarity. For more information on the policy changes implemented for FY 2012, please refer to the FY 2012 IRF PPS final rule (76 FR 47836), in which we published the final FY 2012 IRF federal prospective payment rates.
The FY 2013 IRF PPS notice (77 FR 44618) described the required adjustments to the FY 2013 federal prospective payment rates and outlier threshold amount for IRF discharges occurring on or after
In the FY 2014 IRF PPS final rule (78 FR 47860), we updated the federal prospective payment rates, the CMG relative weights, and the outlier threshold amount. We also updated the facility-level adjustment factors using an enhanced estimation methodology, revised the list of diagnosis codes that count toward an IRF's 60 percent rule compliance calculation to determine "presumptive compliance," revised sections of the Inpatient Rehabilitation Facility-Patient Assessment Instrument (IRF-PAI), revised requirements for acute care hospitals that have IRF units, clarified the IRF regulation text regarding limitation of review, updated references to previously changed sections in the regulations text, and revised and updated quality measures and reporting requirements under the IRF quality reporting program. For more information on the policy changes implemented for FY 2014, please refer to the FY 2014 IRF PPS final rule (78 FR 47860), in which we published the final FY 2014 IRF federal prospective payment rates.
In the FY 2015 IRF PPS final rule (79 FR 45872), we updated the federal prospective payment rates, the CMG relative weights, and the outlier threshold amount. We also further revised the list of diagnosis codes that count toward an IRF's 60 percent rule compliance calculation to determine "presumptive compliance," revised sections of the IRF-PAI, and revised and updated quality measures and reporting requirements under the IRF quality reporting program. For more information on the policy changes implemented for FY 2015, please refer to the FY 2015 IRF PPS final rule (79 FR 45872) and the FY 2015 IRF PPS correction notice (79 FR 59121).
B. Provisions of the Affordable Care Act Affecting the IRF PPS in FY 2012 and Beyond
The Affordable Care Act included several provisions that affect the IRF PPS in FYs 2012 and beyond. In addition to what was previously discussed, section 3401(d) of the Affordable Care Act also added section 1886(j)(3)(C)(ii)(I) (providing for a "productivity adjustment" for fiscal year 2012 and each subsequent fiscal year). The productivity adjustment for FY 2016 is discussed in section V.D. of this proposed rule. Section 3401(d) of the Affordable Care Act requires an additional 0.2 percentage point adjustment to the IRF increase factor for FY 2016, as discussed in section V.D. of this proposed rule. Section 1886(j)(3)(C)(ii)(II) of the Act notes that the application of these adjustments to the market basket update may result in an update that is less than 0.0 for a fiscal year and in payment rates for a fiscal year being less than such payment rates for the preceding fiscal year.
Section 3004(b) of the Affordable Care Act also addressed the IRF PPS program. It reassigned the previously designated section 1886(j)(7) of the Act to section 1886(j)(8) and inserted a new section 1886(j)(7), which contains requirements for the Secretary to establish a quality reporting program for IRFs. Under that program, data must be submitted in a form and manner and at a time specified by the Secretary. Beginning in FY 2014, section 1886(j)(7)(A)(i) of the Act requires the application of a 2 percentage point reduction of the applicable market basket increase factor for IRFs that fail to comply with the quality data submission requirements. Application of the 2 percentage point reduction may result in an update that is less than 0.0 for a fiscal year and in payment rates for a fiscal year being less than such payment rates for the preceding fiscal year. Reporting-based reductions to the market basket increase factor will not be cumulative; they will only apply for the FY involved.
Under section 1886(j)(7)(D)(i) and (ii) of the Act, the Secretary is generally required to select quality measures for the IRF quality reporting program from those that have been endorsed by the consensus-based entity which holds a performance measurement contract under section 1890(a) of the Act. This contract is currently held by the
Section 1886(j)(7)(E) of the Act requires the Secretary to establish procedures for making the IRF PPS quality reporting data available to the public. In so doing, the Secretary must ensure that IRFs have the opportunity to review any such data prior to its release to the public. Future rulemaking will address these public reporting obligations.
C. Operational Overview of the Current IRF PPS
As described in the FY 2002 IRF PPS final rule, upon the admission and discharge of a Medicare Part A Fee-for-Service patient, the IRF is required to complete the appropriate sections of a patient assessment instrument (PAI), designated as the IRF-PAI. In addition, beginning with IRF discharges occurring on or after
The Grouper software produces a 5-character CMG number. The first character is an alphabetic character that indicates the comorbidity tier. The last 4 characters are numeric characters that represent the distinct CMG number. Free downloads of the Inpatient Rehabilitation Validation and Entry (IRVEN) software product, including the Grouper software, are available on the CMS Web site at http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/InpatientRehabFacPPS/Software.html.
Once a Medicare Fee-for-Service Part A patient is discharged, the IRF submits a
Section 3 of the ASCA amends section 1862(a) of the Act by adding paragraph (22), which requires the
Section 3 of the ASCA operates in the context of the administrative simplification provisions of HIPAA, which include, among others, the requirements for transaction standards and code sets codified in 45 CFR parts 160 and 162, subparts A and I through R (generally known as the Transactions Rule). The Transactions Rule requires covered entities, including covered health care providers, to conduct covered electronic transactions according to the applicable transaction standards. (See the CMS program claim memoranda at http://www.cms.gov/ElectronicBillingEDITrans/ and listed in the addenda to the Medicare Intermediary Manual, Part 3, section 3600).
The MAC processes the claim through its software system. This software system includes pricing programming called the "
II. Summary of Provisions of the Proposed Rule
In this proposed rule, we propose to update the IRF federal prospective payment rates, adopt an IRF-specific market basket that will be used to determine the market basket update and labor-related share, phase in the revised wage index changes, and revise and update quality measures and reporting requirements under the IRF QRP.
The proposed updates to the IRF federal prospective payment rates for FY 2016 are as follows:
Update the FY 2016 IRF PPS relative weights and average length of stay values using the most current and complete
Describe the continued use of FY 2014 facility-level adjustment factors as discussed in section IV of this proposed rule.
Adopt the proposed IRF-specific market basket, as discussed in section V of this proposed rule.
Update the FY 2016 IRF PPS payment rates by the proposed market basket increase factor, based upon the most current data available, with a 0.2 percentage point reduction as required by sections 1886(j)(3)(C)(ii)(II) and 1886(j)(3)(D)(iv) of the Act and a proposed productivity adjustment required by section 1886(j)(3)(C)(ii)(I) of the Act, as described in section V of this proposed rule.
Update the FY 2016 IRF PPS payment rates by the FY 2016 wage index and the labor-related share in a budget-neutral manner and discuss the proposed wage adjustment transition as discussed in section V of this proposed rule.
Describe the calculation of the IRF standard payment conversion factor for FY 2016, as discussed in section V of this proposed rule.
Update the outlier threshold amount for FY 2016, as discussed in section VI of this proposed rule.
Update the cost-to-charge ratio (CCR) ceiling and urban/rural average CCRs for FY 2016, as discussed in section VI of this proposed rule.
Discuss implementation of International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for the IRF PPS as discussed in section VII of this proposed rule.
Describe proposed revisions and updates to quality measures and reporting requirements under the quality reporting program for IRFs in accordance with section 1886(j)(7) of the Act, as discussed in section VIII of this proposed rule.
III. Proposed Update to the CMG Relative Weights and Average Length of Stay Values for FY 2016
As specified in section 412.620(b)(1), we calculate a relative weight for each CMG that is proportional to the resources needed by an average inpatient rehabilitation case in that CMG. For example, cases in a CMG with a relative weight of 2, on average, will cost twice as much as cases in a CMG with a relative weight of 1. Relative weights account for the variance in cost per discharge due to the variance in resource utilization among the payment groups, and their use helps to ensure that IRF PPS payments support beneficiary access to care, as well as provider efficiency.
In this proposed rule, we propose to update the CMG relative weights and average length of stay values for FY 2016. As required by statute, we always use the most recent available data to update the CMG relative weights and average lengths of stay. For FY 2016, we propose to use the FY 2014 IRF claims and FY 2013 IRF cost report data. These data are the most current and complete data available at this time. Currently, only a small portion of the FY 2014 IRF cost report data are available for analysis, but the majority of the FY 2014 IRF claims data are available for analysis.
In this proposed rule, we propose to apply these data using the same methodologies that we have used to update the CMG relative weights and average length of stay values each fiscal year since we implemented an update to the methodology to use the more detailed CCR data from the cost reports of IRF subprovider units of primary acute care hospitals, instead of CCR data from the associated primary care hospitals, to calculate IRFs' average costs per case, as discussed in the FY 2009 IRF PPS final rule (73 FR 46372). In calculating the CMG relative weights, we use a hospital-specific relative value method to estimate operating (routine and ancillary services) and capital costs of IRFs. The process used to calculate the CMG relative weights for this proposed rule is as follows:
Step 1. We estimate the effects that comorbidities have on costs.
Step 2. We adjust the cost of each
Step 3. We use the adjusted costs from the second step to calculate CMG relative weights, using the hospital-specific relative value method.
Step 4. We normalize the FY 2016 CMG relative weights to the same average CMG relative weight from the CMG relative weights implemented in the FY 2015 IRF PPS final rule (79 FR 45872).
Consistent with the methodology that we have used to update the IRF classification system in each instance in the past, we propose to update the CMG relative weights for FY 2016 in such a way that total estimated aggregate payments to IRFs for FY 2016 are the same with or without the changes (that is, in a budget-neutral manner) by applying a budget neutrality factor to the standard payment amount. To calculate the appropriate budget neutrality factor for use in updating the FY 2016 CMG relative weights, we use the following steps:
Step 1. Calculate the estimated total amount of IRF PPS payments for FY 2016 (with no changes to the CMG relative weights).
Step 2. Calculate the estimated total amount of IRF PPS payments for FY 2016 by applying the changes to the CMG relative weights (as discussed in this proposed rule).
Step 3. Divide the amount calculated in step 1 by the amount calculated in step 2 to determine the budget neutrality factor (1.0000) that would maintain the same total estimated aggregate payments in FY 2016 with and without the changes to the CMG relative weights.
Step 4. Apply the budget neutrality factor (1.0000) to the FY 2015 IRF PPS standard payment amount after the application of the budget-neutral wage adjustment factor.
In section V.G. of this proposed rule, we discuss the proposed use of the existing methodology to calculate the standard payment conversion factor for FY 2016.
Table 1, "Relative Weights and Average Length of Stay Values for Case-Mix Groups," presents the CMGs, the comorbidity tiers, the corresponding relative weights, and the average length of stay values for each CMG and tier for FY 2016. The average length of stay for each CMG is used to determine when an IRF discharge meets the definition of a short-stay transfer, which results in a per diem case level adjustment.
Table 1--Relative Weights and Average Length of Stay Values for Case-Mix Groups
CMG ..... CMG description (M=motor, C=cognitive, A=age) ..... Relative weight ..... Average length of stay
Tier 1 ..... Tier 2 ..... Tier 3 ..... None ..... Tier 1 ..... Tier 2 ..... Tier 3 ..... None
0101 ..... Stroke, M>51.05 ..... 0.8074 ..... 0.7072 ..... 0.6585 ..... 0.6300 ..... 10 ..... 9 ..... 9 ..... 8
0102 ..... Stroke, M>44.45 and M<51.05 and C>18.5 ..... 1.0213 ..... 0.8946 ..... 0.8329 ..... 0.7968 ..... 11 ..... 10 ..... 10 ..... 10
0103 ..... Stroke, M>44.45 and M<51.05 and C<18.5 ..... 1.1406 ..... 0.9991 ..... 0.9302 ..... 0.8899 ..... 12 ..... 13 ..... 12 ..... 11
0104 ..... Stroke, M>38.85 and M<44.45 ..... 1.2382 ..... 1.0846 ..... 1.0098 ..... 0.9661 ..... 13 ..... 13 ..... 12 ..... 12
0105 ..... Stroke, M>34.25 and M<38.85 ..... 1.4520 ..... 1.2718 ..... 1.1841 ..... 1.1329 ..... 14 ..... 15 ..... 14 ..... 14
0106 ..... Stroke, M>30.05 and M<34.25 ..... 1.6190 ..... 1.4181 ..... 1.3204 ..... 1.2632 ..... 16 ..... 16 ..... 15 ..... 15
0107 ..... Stroke, M>26.15 and M<30.05 ..... 1.8114 ..... 1.5867 ..... 1.4773 ..... 1.4133 ..... 18 ..... 17 ..... 17 ..... 17
0108 ..... Stroke, M<26.15 and A>84.5 ..... 2.2985 ..... 2.0133 ..... 1.8745 ..... 1.7933 ..... 24 ..... 23 ..... 21 ..... 21
0109 ..... Stroke, M>22.35 and M<26.15 and A<84.5 ..... 2.0987 ..... 1.8383 ..... 1.7115 ..... 1.6374 ..... 21 ..... 20 ..... 19 ..... 19
0110 ..... Stroke, M<22.35 and A<84.5 ..... 2.7572 ..... 2.4151 ..... 2.2486 ..... 2.1512 ..... 27 ..... 27 ..... 24 ..... 24
0201 ..... Traumatic brain injury, M>53.35 and C>23.5 ..... 0.8167 ..... 0.6711 ..... 0.6056 ..... 0.5721 ..... 10 ..... 9 ..... 8 ..... 8
0202 ..... Traumatic brain injury, M>44.25 and M<53.35 and C>23.5 ..... 1.0578 ..... 0.8692 ..... 0.7844 ..... 0.7410 ..... 11 ..... 11 ..... 10 ..... 9
0203 ..... Traumatic brain injury, M>44.25 and C<23.5 ..... 1.2056 ..... 0.9906 ..... 0.8939 ..... 0.8445 ..... 11 ..... 12 ..... 10 ..... 11
0204 ..... Traumatic brain injury, M>40.65 and M<44.25 ..... 1.3276 ..... 1.0909 ..... 0.9844 ..... 0.9300 ..... 13 ..... 12 ..... 11 ..... 11
0205 ..... Traumatic brain injury, M>28.75 and M<40.65 ..... 1.5856 ..... 1.3028 ..... 1.1757 ..... 1.1107 ..... 15 ..... 15 ..... 14 ..... 13
0206 ..... Traumatic brain injury, M>22.05 and M<28.75 ..... 1.8996 ..... 1.5609 ..... 1.4086 ..... 1.3306 ..... 17 ..... 18 ..... 17 ..... 15
0207 ..... Traumatic brain injury, M<22.05 ..... 2.5249 ..... 2.0746 ..... 1.8722 ..... 1.7687 ..... 30 ..... 24 ..... 20 ..... 19
0301 ..... Non-traumatic brain injury, M>41.05 ..... 1.1140 ..... 0.9299 ..... 0.8528 ..... 0.7958 ..... 10 ..... 11 ..... 10 ..... 10
0302 ..... Non-traumatic brain injury, M>35.05 and M<41.05 ..... 1.3920 ..... 1.1620 ..... 1.0656 ..... 0.9943 ..... 13 ..... 13 ..... 12 ..... 12
0303 ..... Non-traumatic brain injury, M>26.15 and M<35.05 ..... 1.6177 ..... 1.3504 ..... 1.2384 ..... 1.1556 ..... 16 ..... 15 ..... 14 ..... 14
0304 ..... Non-traumatic brain injury, M<26.15 ..... 2.1480 ..... 1.7930 ..... 1.6443 ..... 1.5344 ..... 22 ..... 20 ..... 18 ..... 17
0401 ..... Traumatic spinal cord injury, M>48.45 ..... 0.9962 ..... 0.8479 ..... 0.7764 ..... 0.7177 ..... 10 ..... 10 ..... 9 ..... 10
0402 ..... Traumatic spinal cord injury, M>30.35 and M<48.45 ..... 1.4305 ..... 1.2175 ..... 1.1149 ..... 1.0306 ..... 14 ..... 14 ..... 14 ..... 13
0403 ..... Traumatic spinal cord injury, M>16.05 and M<30.35 ..... 2.2868 ..... 1.9463 ..... 1.7823 ..... 1.6475 ..... 27 ..... 22 ..... 19 ..... 20
0404 ..... Traumatic spinal cord injury, M<16.05 and A>63.5 ..... 3.8616 ..... 3.2865 ..... 3.0096 ..... 2.7820 ..... 44 ..... 36 ..... 32 ..... 33
0405 ..... Traumatic spinal cord injury, M<16.05 and A<63.5 ..... 3.4241 ..... 2.9142 ..... 2.6687 ..... 2.4668 ..... 41 ..... 34 ..... 29 ..... 28
0501 ..... Non-traumatic spinal cord injury, M>51.35 ..... 0.8671 ..... 0.6910 ..... 0.6416 ..... 0.5890 ..... 9 ..... 7 ..... 8 ..... 8
0502 ..... Non-traumatic spinal cord injury, M>40.15 and M<51.35 ..... 1.1417 ..... 0.9098 ..... 0.8448 ..... 0.7754 ..... 12 ..... 11 ..... 10 ..... 10
0503 ..... Non-traumatic spinal cord injury, M>31.25 and M<40.15 ..... 1.4429 ..... 1.1499 ..... 1.0676 ..... 0.9800 ..... 14 ..... 13 ..... 13 ..... 12
0504 ..... Non-traumatic spinal cord injury, M>29.25 and M<31.25 ..... 1.6605 ..... 1.3232 ..... 1.2286 ..... 1.1278 ..... 16 ..... 16 ..... 14 ..... 13
0505 ..... Non-traumatic spinal cord injury, M>23.75 and M<29.25 ..... 1.9434 ..... 1.5487 ..... 1.4379 ..... 1.3200 ..... 19 ..... 17 ..... 16 ..... 16
0506 ..... Non-traumatic spinal cord injury, M<23.75 ..... 2.7170 ..... 2.1652 ..... 2.0104 ..... 1.8454 ..... 27 ..... 24 ..... 22 ..... 21
0601 ..... Neurological, M>47.75 ..... 1.0388 ..... 0.8197 ..... 0.7649 ..... 0.6911 ..... 10 ..... 10 ..... 9 ..... 9
0602 ..... Neurological, M>37.35 and M<47.75 ..... 1.3344 ..... 1.0529 ..... 0.9825 ..... 0.8878 ..... 12 ..... 12 ..... 11 ..... 11
0603 ..... Neurological, M>25.85 and M<37.35 ..... 1.6570 ..... 1.3074 ..... 1.2201 ..... 1.1024 ..... 15 ..... 14 ..... 13 ..... 13
0604 ..... Neurological, M<25.85 ..... 2.1771 ..... 1.7178 ..... 1.6031 ..... 1.4485 ..... 20 ..... 18 ..... 17 ..... 16
0701 ..... Fracture of lower extremity, M>42.15 ..... 0.9663 ..... 0.8091 ..... 0.7663 ..... 0.6961 ..... 11 ..... 9 ..... 9 ..... 9
0702 ..... Fracture of lower extremity, M>34.15 and M<42.15 ..... 1.2542 ..... 1.0502 ..... 0.9947 ..... 0.9035 ..... 13 ..... 12 ..... 12 ..... 11
0703 ..... Fracture of lower extremity, M>28.15 and M<34.15 ..... 1.5016 ..... 1.2574 ..... 1.1909 ..... 1.0817 ..... 14 ..... 14 ..... 14 ..... 13
0704 ..... Fracture of lower extremity, M<28.15 ..... 1.9536 ..... 1.6359 ..... 1.5494 ..... 1.4073 ..... 18 ..... 18 ..... 17 ..... 16
0801 ..... Replacement of lower extremity joint, M>49.55 ..... 0.8023 ..... 0.6319 ..... 0.5733 ..... 0.5295 ..... 8 ..... 8 ..... 7 ..... 7
0802 ..... Replacement of lower extremity joint, M>37.05 and M<49.55 ..... 1.0579 ..... 0.8332 ..... 0.7560 ..... 0.6981 ..... 10 ..... 10 ..... 9 ..... 9
0803 ..... Replacement of lower extremity joint, M>28.65 and M<37.05 and A>83.5 ..... 1.4254 ..... 1.1227 ..... 1.0186 ..... 0.9407 ..... 13 ..... 12 ..... 12 ..... 11
0804 ..... Replacement of lower extremity joint, M>28.65 and M<37.05 and A<83.5 ..... 1.2747 ..... 1.0040 ..... 0.9109 ..... 0.8412 ..... 12 ..... 11 ..... 11 ..... 10
0805 ..... Replacement of lower extremity joint, M>22.05 and M<28.65 ..... 1.5372 ..... 1.2107 ..... 1.0985 ..... 1.0145 ..... 15 ..... 14 ..... 12 ..... 12
0806 ..... Replacement of lower extremity joint, M<22.05 ..... 1.9126 ..... 1.5064 ..... 1.3668 ..... 1.2622 ..... 17 ..... 17 ..... 15 ..... 14
0901 ..... Other orthopedic, M>44.75 ..... 0.9548 ..... 0.7679 ..... 0.7038 ..... 0.6416 ..... 10 ..... 9 ..... 9 ..... 8
0902 ..... Other orthopedic, M>34.35 and M<44.75 ..... 1.2720 ..... 1.0231 ..... 0.9377 ..... 0.8547 ..... 13 ..... 12 ..... 11 ..... 11
0903 ..... Other orthopedic, M>24.15 and M<34.35 ..... 1.5872 ..... 1.2767 ..... 1.1701 ..... 1.0666 ..... 14 ..... 14 ..... 13 ..... 13
0904 ..... Other orthopedic, M<24.15 ..... 2.0061 ..... 1.6136 ..... 1.4789 ..... 1.3481 ..... 19 ..... 18 ..... 16 ..... 16
1001 ..... Amputation, lower extremity, M>47.65 ..... 1.0786 ..... 0.9456 ..... 0.8420 ..... 0.7598 ..... 11 ..... 11 ..... 10 ..... 10
1002 ..... Amputation, lower extremity, M>36.25 and M<47.65 ..... 1.3378 ..... 1.1728 ..... 1.0443 ..... 0.9423 ..... 13 ..... 12 ..... 12 ..... 11
1003 ..... Amputation, lower extremity, M<36.25 ..... 1.9202 ..... 1.6835 ..... 1.4990 ..... 1.3526 ..... 18 ..... 19 ..... 17 ..... 16
1101 ..... Amputation, non-lower extremity, M>36.35 ..... 1.3537 ..... 1.3537 ..... 1.0753 ..... 1.0104 ..... 13 ..... 13 ..... 12 ..... 11
1102 ..... Amputation, non-lower extremity, M<36.35 ..... 1.7741 ..... 1.7741 ..... 1.4093 ..... 1.3242 ..... 16 ..... 19 ..... 15 ..... 16
1201 ..... Osteoarthritis, M>37.65 ..... 0.9828 ..... 0.9542 ..... 0.8689 ..... 0.8106 ..... 9 ..... 11 ..... 10 ..... 10
1202 ..... Osteoarthritis, M>30.75 and M<37.65 ..... 1.1972 ..... 1.1624 ..... 1.0585 ..... 0.9875 ..... 11 ..... 14 ..... 13 ..... 12
1203 ..... Osteoarthritis, M<30.75 ..... 1.4863 ..... 1.4431 ..... 1.3140 ..... 1.2259 ..... 14 ..... 16 ..... 15 ..... 14
1301 ..... Rheumatoid, other arthritis, M>36.35 ..... 1.1640 ..... 0.9591 ..... 0.9044 ..... 0.8258 ..... 9 ..... 11 ..... 10 ..... 10
1302 ..... Rheumatoid, other arthritis, M>26.15 and M<36.35 ..... 1.4812 ..... 1.2205 ..... 1.1509 ..... 1.0509 ..... 15 ..... 13 ..... 13 ..... 13
1303 ..... Rheumatoid, other arthritis, M<26.15 ..... 1.9711 ..... 1.6241 ..... 1.5314 ..... 1.3984 ..... 21 ..... 18 ..... 17 ..... 16
1401 ..... Cardiac, M>48.85 ..... 0.9070 ..... 0.7454 ..... 0.6741 ..... 0.6066 ..... 9 ..... 9 ..... 8 ..... 8
1402 ..... Cardiac, M>38.55 and M<48.85 ..... 1.2037 ..... 0.9893 ..... 0.8946 ..... 0.8050 ..... 11 ..... 11 ..... 11 ..... 10
1403 ..... Cardiac, M>31.15 and M<38.55 ..... 1.4509 ..... 1.1924 ..... 1.0783 ..... 0.9703 ..... 13 ..... 13 ..... 12 ..... 12
1404 ..... Cardiac, M<31.15 ..... 1.8350 ..... 1.5081 ..... 1.3637 ..... 1.2271 ..... 17 ..... 16 ..... 15 ..... 14
1501 ..... Pulmonary, M>49.25 ..... 1.0508 ..... 0.8465 ..... 0.7794 ..... 0.7499 ..... 11 ..... 10 ..... 9 ..... 9
1502 ..... Pulmonary, M>39.05 and M<49.25 ..... 1.3338 ..... 1.0745 ..... 0.9893 ..... 0.9519 ..... 12 ..... 12 ..... 11 ..... 11
1503 ..... Pulmonary, M>29.15 and M<39.05 ..... 1.6182 ..... 1.3036 ..... 1.2002 ..... 1.1549 ..... 15 ..... 13 ..... 13 ..... 13
1504 ..... Pulmonary, M<29.15 ..... 2.0127 ..... 1.6215 ..... 1.4928 ..... 1.4364 ..... 21 ..... 17 ..... 15 ..... 15
1601 ..... Pain syndrome, M>37.15 ..... 1.1408 ..... 0.8388 ..... 0.8240 ..... 0.7577 ..... 11 ..... 10 ..... 10 ..... 9
1602 ..... Pain syndrome, M>26.75 and M<37.15 ..... 1.4837 ..... 1.0909 ..... 1.0718 ..... 0.9854 ..... 14 ..... 12 ..... 12 ..... 12
1603 ..... Pain syndrome, M<26.75 ..... 1.9166 ..... 1.4093 ..... 1.3845 ..... 1.2730 ..... 15 ..... 15 ..... 15 ..... 15
1701 ..... Major multiple trauma without brain or spinal cord injury, M>39.25 ..... 1.0739 ..... 0.9109 ..... 0.8312 ..... 0.7736 ..... 10 ..... 10 ..... 11 ..... 9
1702 ..... Major multiple trauma without brain or spinal cord injury, M>31.05 and M<39.25 ..... 1.3886 ..... 1.1779 ..... 1.0748 ..... 1.0002 ..... 13 ..... 14 ..... 12 ..... 12
1703 ..... Major multiple trauma without brain or spinal cord injury, M>25.55 and M<31.05 ..... 1.5890 ..... 1.3479 ..... 1.2299 ..... 1.1446 ..... 19 ..... 15 ..... 14 ..... 14
1704 ..... Major multiple trauma without brain or spinal cord injury, M<25.55 ..... 2.0894 ..... 1.7724 ..... 1.6172 ..... 1.5051 ..... 21 ..... 20 ..... 18 ..... 17
1801 ..... Major multiple trauma with brain or spinal cord injury, M>40.85 ..... 1.2728 ..... 0.9643 ..... 0.8811 ..... 0.7840 ..... 14 ..... 12 ..... 11 ..... 10
1802 ..... Major multiple trauma with brain or spinal cord injury, M>23.05 and M<40.85 ..... 1.8675 ..... 1.4148 ..... 1.2928 ..... 1.1503 ..... 19 ..... 17 ..... 15 ..... 14
1803 ..... Major multiple trauma with brain or spinal cord injury, M<23.05 ..... 3.0253 ..... 2.2920 ..... 2.0942 ..... 1.8635 ..... 31 ..... 26 ..... 21 ..... 21
1901 ..... Guillain Barre, M>35.95 ..... 1.1501 ..... 0.9999 ..... 0.9724 ..... 0.8501 ..... 15 ..... 11 ..... 11 ..... 11
1902 ..... Guillain Barre, M>18.05 and M<35.95 ..... 2.2469 ..... 1.9534 ..... 1.8997 ..... 1.6609 ..... 25 ..... 22 ..... 21 ..... 20
1903 ..... Guillain Barre, M<18.05 ..... 3.6057 ..... 3.1347 ..... 3.0485 ..... 2.6652 ..... 48 ..... 31 ..... 28 ..... 30
2001 ..... Miscellaneous, M>49.15 ..... 0.9280 ..... 0.7626 ..... 0.7034 ..... 0.6367 ..... 9 ..... 9 ..... 9 ..... 8
2002 ..... Miscellaneous, M>38.75 and M<49.15 ..... 1.2002 ..... 0.9863 ..... 0.9097 ..... 0.8235 ..... 11 ..... 11 ..... 10 ..... 10
2003 ..... Miscellaneous, M>27.85 and M<38.75 ..... 1.4940 ..... 1.2277 ..... 1.1324 ..... 1.0250 ..... 14 ..... 14 ..... 13 ..... 12
2004 ..... Miscellaneous, M<27.85 ..... 1.9243 ..... 1.5813 ..... 1.4586 ..... 1.3203 ..... 18 ..... 17 ..... 16 ..... 15
2101 ..... Burns, M>0 ..... 1.6922 ..... 1.6922 ..... 1.3135 ..... 1.2742 ..... 18 ..... 19 ..... 15 ..... 15
5001 ..... Short-stay cases, length of stay is 3 days or fewer ..... ..... ..... ..... 0.1562 ..... ..... ..... ..... 2
5101 ..... Expired, orthopedic, length of stay is 13 days or fewer ..... ..... ..... ..... 0.7204 ..... ..... ..... ..... 8
5102 ..... Expired, orthopedic, length of stay is 14 days or more ..... ..... ..... ..... 1.6962 ..... ..... ..... ..... 18
5103 ..... Expired, not orthopedic, length of stay is 15 days or fewer ..... ..... ..... ..... 0.7928 ..... ..... ..... ..... 9
5104 ..... Expired, not orthopedic, length of stay is 16 days or more ..... ..... ..... ..... 1.9018 ..... ..... ..... ..... 20
Generally, updates to the CMG relative weights result in some increases and some decreases to the CMG relative weight values. Table 2 shows how we estimate that the application of the proposed revisions for FY 2016 would affect particular CMG relative weight values, which would affect the overall distribution of payments within CMGs and tiers. Note that, because we propose to implement the CMG relative weight revisions in a budget-neutral manner (as previously described), total estimated aggregate payments to IRFs for FY 2016 would not be affected as a result of the proposed CMG relative weight revisions. However, the proposed revisions would affect the distribution of payments within CMGs and tiers.
Table 2--Distributional Effects of the Changes to the CMG Relative Weights
Percentage change ..... Number of cases affected ..... Percentage of cases affected
[FY 2015 values compared with FY 2016 values]
Increased by 15% or more ..... 157 ..... 0.0
Increased by between 5% and 15% ..... 2,292 ..... 0.6
Changed by less than 5% ..... 353,020 ..... 99.0
Decreased by between 5% and 15% ..... 1,195 ..... 0.3
Decreased by 15% or more ..... 63 ..... 0.0
As Table 2 shows, 99 percent of all IRF cases are in CMGs and tiers that would experience less than a 5 percent change (either increase or decrease) in the CMG relative weight value as a result of the proposed revisions for FY 2016. The largest estimated increase in the proposed CMG relative weight values that affects the largest number of IRF discharges would be a 0.2 percent increase in the CMG relative weight value for CMG 0704--Fracture of lower extremity, with a motor score less than 28.15-in the "no comorbidity" tier. In the FY 2014 claims data, 17,812 IRF discharges (5.0 percent of all IRF discharges) were classified into this CMG and tier.
The largest decrease in a CMG relative weight value affecting the largest number of IRF cases would be a 0.8 percent decrease in the CMG relative weight for CMG 0604--Neurological, with a motor score less than 25.85-in the "no comorbidity" tier. In the FY 2014 IRF claims data, this change would have affected 8,544 cases (2.4 percent of all IRF cases).
The proposed changes in the average length of stay values for FY 2016, compared with the FY 2015 average length of stay values, are small and do not show any particular trends in IRF length of stay patterns.
We invite public comment on our proposed update to the CMG relative weights and average length of stay values for FY 2016.
Dated:
Acting Administrator,
Dated:
<p>
Secretary,
Editor's note: For the full-text of this document, click this link or copy it into your browser: https://www.federalregister.gov/articles/2015/04/27/2015-09617/medicare-program-inpatient-rehabilitation-facility-prospective-payment-system-for-federal-fiscal.
-1202349
VA to Amend Medical Regulations by Updating Certain Delegations of Authority
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News